The SAGE Encyclopedia of Stem Cell Research. Группа авторов
Stem-Cell Transplantation. New England Journal of Medicine, v.343 (2000).
Cutler, C. and J. H. Antin. “Peripheral Blood Stem Cells for Allogeneic Transplantation: A Review.” Stem Cells, v.19 (2001).
De Filippo, R. E., J. J. Yoo, and A. Atala. “Engineering of Vaginal Tissue in Vivo.” Tissue Engineering, v.9 (2003).
de Miguel, M. P., S. Fuentes-Julián, and Y. Alcaina, “Pluripotent Stem Cells: Origin, Maintenance and Induction.” Stem Cell Reviews and Reports, v.6/4 (2010).
Doetschman, T., H. Eistetter, M. Katz, et al. “The in Vitro Development of Blastocyst-Derived Embryonic Stem Cell Lines: Formation of Visceral Yolk Sac, Blood Islands and Myocardium.” Journal of Embryology and Experimental Morphology, v.87 (1985).
Domen, J. and I. L. Weissman. “Hematopoietic Stem Cells Need Two Signals to Prevent Apoptosis; BCL-2 Can Provide One of These, Kitl/c-Kit Signaling the Other.” Journal of Experimental Medicine, v.192/12 (2000).
Dor, Y., J. Brown, O. I. Martinez, et al. “Adult Pancreatic Beta-Cells Are Formed by Self-duplication Rather Than Stem-Cell Differentiation.” Nature, v.429 (2004).
Dzierzak, E. “Embryonic Beginnings of Definitive Hematopoietic Stem Cells.” Annals of the New York Academy of Sciences, v.872 (1999).
Dzierzak, E., A. Medvinsky, and M. de Bruijn. “Qualitative and Quantitative Aspects of Hematopoietic Cell Development in the Mammalian Embryo.” Immunology Today, v.19/5 (1998).
Ema, H., H. Takano, K. Sudo, et al. “In Vitro Self-Renewal Division of Hematopoietic Stem Cells.” Journal of Experimental Medicine, v.192/9 (2000).
Evans, M. J. and M. H. Kaufman. “Establishment in Culture of Pluripotential Cells From Mouse Embryos.” Nature, v.292/5819 (1981).
Ferranninni, E. “Insulin Resistance Versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and Prospects.” Endocrine Reviews, v.19. (1998).
Gallacher, L., B. Murdoch, D. Wu, et al. “Identification of Novel Circulating Human Embryonic Blood Stem Cells.” Blood, v.96/5 (2000).
Guz, Y., I. Nasir, and G. Teitelman. “Regeneration of Pancreatic Beta Cells From Intra-Islet Precursor Cells in an Experimental Model of Diabetes.” Endocrinology, v.142 (2001).
Hill, J. O. and J. C. Peters. “Environmental Contributions to the Obesity Epidemic.” Science, v.280 (1998).
Hull, M. G., C. M. Glazener, N. J. Kelly, et al. “Population Study of Causes, Treatment, and Outcome of Infertility.” British Medical Journal, v.291/6510 (1985).
King, H., R. E. Aubert, and W. H. Herman. “Global Burden of Diabetes, 1995–2025: Prevalence, Numerical Estimates, and Projections.” Diabetes Care, v.21 (1998).
Kolios, G. and Y. Moodley. “Introduction to Stem Cells and Regenerative Medicine.” Respiration, v.85/1 (2013).
Lee, C. S., D. D. De Leon, K. H. Kaestner, et al. “Regeneration of Pancreatic Islets After Partial Pancreatectomy in Mice Does Not Involve the Reactivation of Neurogenin-3.” Diabetes, v.55 (2006).
Lipsett, M. and D. T. Finegood. “Beta-Cell Neogenesis during Prolonged Hyperglycemia in Rats.” Diabetes, v.51 (2001).
Minami, K., M. Okuno, K. Miyawaki, et al. “Lineage Tracing and Characterization of Insulin-Secreting Cells Generated From Adult Pancreatic Acinar Cells.” Proceedings of the National Academy of Sciences of the USA, v.102/42 (2005).
Narayan, K. M., J. P. Boyle, T. J. Thompson, et al. “Lifetime Risk for Diabetes Mellitus in the United States.” JAMA, v.290 (2003).
Oshima, Y., A. Suzuki, K. Kawashimo, et al. “Isolation of Mouse Pancreatic Ductal Progenitor Cells Expressing CD133 and c-Met by Flow Cytometric Cell Sorting.” Gastroenterology, v.132 (2007).
Raimya, V. K., M. Maraist, K. E. Arfors, et al. “Reversal of Insulin-Dependent Diabetes Using Islets Generated in Vitro From Pancreatic Stem Cells.” Nature Medicine, v.6/3 (2000).
Ratajczak, M. Z., E. Zuba-Surma, M. Kucia, et al. “Pluripotent and Multipotent Stem Cells in Adult Tissues.” Advances in Medical Sciences, v.57/1 (2012).
Rossant, J. “Stem Cells from the Mammalian Blastocyst.” Stem Cells, v.19/6 (2001).
Ryan, E. A., J. R. Lakey, B. W. Paty, et al. “Successful Islet Transplantation: Continued Insulin Reserve Provides Long-Term Glycemic Control.” Diabetes, v.51 (2002).
Ryan, E. A., J. R. Lakey, R. V. Rajotte, et al. “Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol.” Diabetes, v.50 (2001).
Ryan, E. A., B. W. Paty, P. A. Senior, et al. “Five-Year Follow-Up After Clinical Islet Transplantation.” Diabetes, v.54 (2005).
Scharp, D. W., P. E. Lacy, J. V. Santiago, et al. “Insulin Independence After Islet Transplantation Into Patient.” Diabetes, v.39 (1990).
Seaberg, R. M., S. R. Smukler, T. J. Kieffer, et al. “Clonal Identification of Multipotent Precursors From Adult Mouse Pancreas That Generate Neural and Pancreatic Lineages.” Nature Biotechnology, v.22/9 (2004).
Shapiro, A. M., J. R. Lakey, E. A. Ryan, et al. “Islet Transplantation in Seven Patients With Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen.” New England Journal of Medicine, v.343 (2000).
Soria, B., F. J. Bedoya, and F. Martin. “Gastrointestinal Stem Cells: I. Pancreatic Stem Cells.” American Journal of Physiology, Gastrointestinal and Liver Physiology, v./2 (2005).
Tan, S.-L., P. Doyle, S. Campbell, et al. “Obstetric Outcome of in Vitro Fertilization Pregnancies Compared With Normally Conceived Pregnancies.” American Journal of Obstetrics and Gynecology, v.167/3 (1992).
Tsang, W. G., T. Zheng, Y. Wang, et al. “Generation of Functional Islet-Like Clusters After Monolayer Culture and Intracapsular Aggregation of Adult Human Pancreatic Islet Tissue.” Transplantation, v.83 (2007).
UK Prospective Diabetes Study Group. “Overview of 6 Years’ Therapy of Type II Diabetes: A Progressive Disease” (UKPDS 16). Diabetes, v.44 (1995).
Volarevic, V., B. Ljujic, P. Stojkovic, et al. “Human Stem Cell Research and Regenerative Medicine—Present and Future.” British Medical Bulletin, v.99/1 (2011).
Xu, X., J. D’Hoker, G. Stangé, et al. “Beta Cells Can Be Generated From Endogenous Progenitors in Injured Adult Mouse Pancreas.” Cell, v.132 (2008).
Zimmet, P., K. G. Alberti, and J. Shaw. “Global and Societal Implications of the Diabetes Epidemic.” Nature, v.414 (2001).
Zulewski, H. “Stem Cells With Potential to Generate Insulin-Producing Cells in Man.” Swiss Medical Weekly, v.136/41–42 (2006).
Zulewski, H., E. J. Abraham, M. J. Gerlach, et al. “Multipotential Nestin-Positive Stem Cells Isolated From Adult Pancreatic Islets Differentiate Ex Vivo Into Pancreatic Endocrine, Exocrine, and Hepatic Phenotypes.” Diabetes, v.50 (2001).
Advanced Cell Technology
Advanced Cell Technology
25
27
Advanced Cell Technology
Advanced Cell Technology (ACT) is a biotechnology company that specializes in developing cellular therapies to treat human diseases and was one of the first companies to run an FDA-approved clinical trial based on embryonic stem cells. The corporate offices and principal laboratory for ACT are located in Marlborough, Massachusetts,